NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
Overview | Financials
Company Name | NRx Pharmaceuticals, Inc. |
Symbol | NRXP |
Currency | USD |
Price | 2.69 |
Market Cap | 32,533,129 |
Dividend Yield | 0% |
52-week-range | 1.1 - 7.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Stephen H. Willard Esq. |
Website | https://www.nrxpharma.com |
An error occurred while fetching data.
About NRx Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD